Abivax SA posts Q1 loss wider than expected, revenue beats estimates
Abivax SA reported a quarterly adjusted loss of 61 cents per share for the quarter ended March 31, a wider loss than the -83 cents reported in the same quarter last year, and beating the mean expectation of five analysts for a loss of 100 cents per share. Revenue rose 20.8% to €994.00 thousand from a year ago, beating